Provided by Tiger Fintech (Singapore) Pte. Ltd.

Kiniksa Pharmaceuticals Ltd.

35.71
+0.20000.56%
Post-market: 36.000.2900+0.81%16:40 EDT
Volume:328.23K
Turnover:11.68M
Market Cap:2.65B
PE:540.77
High:35.84
Open:35.53
Low:35.12
Close:35.51
52wk High:35.84
52wk Low:17.82
Shares:74.11M
Float Shares:33.55M
Volume Ratio:0.75
T/O Rate:0.98%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.0660
EPS(LYR):-0.6047
ROE:1.03%
ROA:0.46%
PB:5.35
PE(LYR):-59.05

Loading ...

Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 06, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 29, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 29, 2024

Major Issues Report

Form 8-K - Current report
Oct 15, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 08, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Oct 08, 2024

Major Issues Report

Form 8-K - Current report
Sep 23, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 27, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 25, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 23, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 23, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 23, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 23, 2024

Notice Of Suspension

Form 15-15D/A - Suspension of duty to report [Section 13 and 15(d)]: [Amend]
Jul 23, 2024

Major Issues Report

Form 8-K - Current report
Jul 02, 2024

Correspondence

Form CORRESP - Correspondence
Jun 28, 2024

Notice Of Suspension

Form 15-15D - Suspension of duty to report [Section 13 and 15(d)]
Jun 28, 2024

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments